Cargando…
Rosuvastatin alters the genetic composition of the human gut microbiome
The gut microbiome contributes to the variation of blood lipid levels, and secondary bile acids are associated with the effect of statins. Yet, our knowledge of how statins, one of our most common drug groups, affect the human microbiome is scarce. We aimed to characterize the effect of rosuvastatin...
Autores principales: | Kummen, Martin, Solberg, Ole Geir, Storm-Larsen, Christopher, Holm, Kristian, Ragnarsson, Asgrimur, Trøseid, Marius, Vestad, Beate, Skårdal, Rita, Yndestad, Arne, Ueland, Thor, Svardal, Asbjørn, Berge, Rolf K., Seljeflot, Ingebjørg, Gullestad, Lars, Karlsen, Tom H., Aaberge, Lars, Aukrust, Pål, Hov, Johannes R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096534/ https://www.ncbi.nlm.nih.gov/pubmed/32214138 http://dx.doi.org/10.1038/s41598-020-62261-y |
Ejemplares similares
-
Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020) -
Microvascular function and inflammatory activation in Takotsubo cardiomyopathy
por: Solberg, Ole Geir, et al.
Publicado: (2023) -
The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial
por: Broch, Kaspar, et al.
Publicado: (2014) -
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
por: Askevold, Erik Tandberg, et al.
Publicado: (2015) -
Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
por: Jørgensen, S. F., et al.
Publicado: (2019)